Dr. Daniela Friedman Coordinates Upcoming Prostate Cancer Screening Symposium
Dr. Daniela B. Friedman, an assistant professor in the Arnold School of Public Health and a Science and Health Communication Research Group member, is the co-planner of a symposium with Dr. Charles Bennett (SC School of Pharmacy Endowed Chair) on prostate cancer screening that will take place at the University of South Carolina next month. Dr. Friedman’s pilot research, funded by grants from the National Cancer Institute and South Carolina Cancer Alliance, examines African-American families’ communication and decision-making practices around prostate cancer screening. Friedman is also prostate cancer workgroup co-lead of the South Carolina Cancer Alliance, a statewide nonprofit cancer organization dedicated to reducing cancer burden in South Carolina.
Communicating effectively about prostate cancer is especially important given that African-American men in South Carolina have a prostate cancer death rate that is about 2.5 times that of European-American men and current guidelines from the American Cancer Society recommend that men make an informed decision with their provider about whether or not to get screened.
The “Pros and Cons of Prostate Cancer Screening” symposium will be held Thursday, Sept. 15 at 3 p.m. in USC’s Russell House Theater.
The symposium will feature two of the nation’s leading experts on prostate cancer, Dr. Richard Ablin, who discovered the prostate specific antigen (PSA) and Dr. Oliver Sartor, the principal investigator for pivotal clinical trials for two of the most recently discovered treatments for prostate cancer.
“This event will start an important statewide dialogue about the challenges of the prostate specific antigen (PSA) test for detecting prostate cancer. The goal of our research and education in this area is to help communities at high risk for prostate cancer make informed decisions about cancer screening and about their overall health,” said Friedman.
The event on Sept. 15 is free and open to the public. The symposium is sponsored by USC’s Arnold School of Public Health and the Cancer Prevention and Control Program, the South Carolina College of Pharmacy and the South Carolina Center for Economic Excellence in Medication Safety and Efficacy.
For the full article about the symposium, click here.